Cade David Norman 3 Filing

From the Filing

EDGAR Filing Documents for 0001628280-26-022572 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 3 - Initial statement of beneficial ownership of securities: SEC Accession No. 0001628280-26-022572 Filing Date 2026-04-01 Accepted 2026-04-01 07:25:31 Documents 4 Period of Report 2026-03-18 Document Format Files Seq Description Document Type Size 1 FORM 3 wk-form3_1775042725.html 3 1 FORM 3 wk-form3_1775042725.xml 3 7681 2 EX-24 poa-davidcade.htm EX-24 5488 3 GRAPHIC poa-davidcade001.jpg GRAPHIC 238743 4 poa-davidcade002.jpg GRAPHIC 95759 Complete submission text file 0001628280-26-022572.txt 475498 Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855 Telix Pharmaceuticals Ltd ( Issuer ) CIK : 0002007191 (see all company filings) EIN. : 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences) Mailing Address 55 FLEMINGTON ROAD, LEVEL 4 NORTH MELBOURNE VICTORIA Australia 3051 Business Address Cade David Norman ( Reporting ) CIK : 0002123007 (see all company filings) Type: 3 | Act: 34 | File No.: 001-42128 | Film No.: 26824691